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Simulation phase: given the statistical nature of these 
relationships, we reserved one cartridge of each connectors 
type to assure that we would not run out of them when the 
surgical procedure took place. A retrospectively application 
of these formulae yielded that we would had used only those 
corresponding A, B, C reserved cartridges in 14%, 19% and 
12% of the procedures. We would have had only to add that 
spent cartridge when placing the following order. 
Conclusions: When LDR-brachytherapy seeds implant with 
needle loading on demand technique is used the quantity of 
the different types of seed connectors can be statistically 
expressed in terms of the preoperative prostate volume. With 
enough experience in the implant technique and preoperative 
prostate volumetric study it is possible to mark out 
institution-specific bounds to each of these quantities. It 
optimizes the preoperative prediction of seeds connectors, 
seeds and needles that will be used and reduces costs in 
material and storage.  
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Purpose/Objective: To analyze the twelve years outcomes of 
I-125 LDR brachytherapy in Turkish men with low-
intermediate risk localized prostate cancer.  
Materials and Methods: Between 2000-2004, 139 patients 
treated with LDR brachytherapy were analyzed 
retrospectively. Brachytherapy was monotherapy in 127 
pts.and used with external beam radiotherapy in 12 pts. Four 
pts excluded from study due to protocol deviation. 135 pts 
were analyzed for disease control and survival. For all the pts 
preplanning was done in treatment conditions. During the 
aplication real time planning was used. Four- six weeks after 
application postplanning dosimetry was done with CT and MR 
images. In dosimetry D90, V100, V150, V200, V250 for 
prostate; V100, V150 for urethra ; V100, dose at 4 cc for 
rectum were evaluated. Survival curves were calculated using 
the Kaplan- Meier method, and the significance was 
calculated by the log-rank test. To compare the prognostic 
factors Chi- square test was used.  
Results: The median follow-up time was 88 months ( 6-170 
months). The median age of 135 pts. Was 65 years (44-81 
years). In pts 64.4 % of them were in low risk and 35.6 % in 
intermediate risk. The mean PSA value at diagnosis was 8,12 
ng/ml (SD ±6,33). In 43.2 % of the pts received androgen 
deprivation for 3 months before procedure . T stages were 
T1c in 12 pts, T2a in 64 pts, T2b in 53 pts and T3 in 6 pts. 
During procedure median 28 (18-35) needles and 85 (65-110) 
seeds at 0.49 U/seed(0.43-0.50) were used. Prescribed dose 
was set at 145 Gy in monotherapy and 110 Gy in combined 
treatment. Treatment results were given in table 1.  
 
 
 
Conclusions: Our results are in concordance and comparable 
with other reports on I-125 LDR prostate brachytherapy. 
    
 
Electronic Poster: Brachytherapy track: Anorectal  
 
 
EP-1611   
HDR intestinal brachytherapy as a salvage treatment in 
rectal adenocarcinoma patients 
D.K. Kazberuk1, T.F. Filipowski1, W.M. Markiewicz2, D.H. 
Hempel1, M.N. Niksa1, A.S.Z.T. Szmigiel-Trzcinska1, J.T.B. 
Topczewska-Bruns1, B.P.J. Pancewicz-Janczuk3 
1Bialystok Comprehensive Cancer Center, Radiation 
Oncology, Bialystok, Poland  
2Bialystok Comprehensive Cancer Center, Oncological 
Surgery, Bialystok, Poland  
3Bialystok Comprehensive Cancer Center, Physics, Bialystok, 
Poland  
 
Purpose/Objective: To analyze efficacy and toxicity profile 
of intestinal HDR brachytherapy in rectal Adenocarcinoma 
patients after tumorectomy as a salvage treatment. 
Materials and Methods: Between April 2009 and July 2014 15 
patients (pts) with adenocarcinoma underwent conformal 
HDR brachytherapy (HDR-BRT) with a temporary intestinal 
implants (2-7 catheters). The mean age of pts was 70,47 ( 
range 45-87). Twelve of patients received 30 Gy in 5 days (3 
Gy per fraction) twice daily. One patient received 24 Gy in 6 
days (4 Gy per fraction). One patient received 10 Gy in single 
fraction. One patient received 15 Gy in five days (3 Gy per 
